Q3 2018 Holdings
Filed 2018-11-14 | 51 holdings | $124.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $77.0M | 1,087,257 | 61.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $31.2M | 2,236,387 | 25.0% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $11.6M | 1,231,800 | 9.3% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.0M | 351,401 | 2.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $844.0K | 50,000 | 0.7% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $122.5K | 2,017,250 | 0.1% |
| Assembly Biosciences Inc | COM | 045396108 | $109.3K | 2,943,164 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM | 46333X108 | $94.9K | 5,141,624 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $68.3K | 3,902,975 | 0.1% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $61.0K | 2,367,378 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $58.0K | 3,802,327 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $45.7K | 837,048 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $31.8K | 1,481,086 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $27.6K | 1,288,198 | 0.0% |
| Akcea Therapeutics Inc(AKCAEUR) | COM | 00972L107 | $26.4K | 755,120 | 0.0% |
| Ultragenyx PharmaceuticalCall | COM | 90400D908 | $24.8K | 325,000 | 0.0% |
| Gilead Sciences IncCall | COM | 375558903 | $22.6K | 292,600 | 0.0% |
| Crispr Therapeutics AG(CRSP) | COM | H17182108 | $22.2K | 500,000 | 0.0% |
| Fibrogen IncCall | COM | 31572Q908 | $21.3K | 350,000 | 0.0% |
| Nektar TherapeuticsCall | COM | 640268908 | $19.8K | 325,000 | 0.0% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $19.4K | 254,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $18.5K | 1,538,088 | 0.0% |
| Ascendis Pharma A SCall | COM | 04351P901 | $18.2K | 257,000 | 0.0% |
| Celgene CorporationCall | COM | 151020904 | $17.9K | 200,000 | 0.0% |
| Unity Biotechnology Inc. | COM | 91381U101 | $15.8K | 967,114 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $14.9K | 1,363,479 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $14.2K | 592,128 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $12.5K | 1,039,500 | 0.0% |
| Ironwood Pharmaceuticals IncCall | COM | 46333X908 | $10.5K | 567,600 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $9.4K | 892,741 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $7.7K | 2,241,900 | 0.0% |
| ZAI LAB LTD(ZLAB) | SPONSORED ADR | 98887Q104 | $6.8K | 350,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $6.6K | 2,265,880 | 0.0% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $6.6K | 190,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $5.8K | 343,231 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $5.8K | 1,564,080 | 0.0% |
| Assembly Biosciences IncCall | COM | 045396908 | $5.5K | 148,100 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $5.0K | 495,618 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $4.9K | 1,480,870 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.7K | 72,326 | 0.0% |
| Onconova Therapeutics Inc | COM | 68232V405 | $3.7K | 500,000 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $3.6K | 68,646 | 0.0% |
| Jounce Therapeutics IncCall | COM | 481116901 | $3.2K | 497,400 | 0.0% |
| Wave Life Sciences LTD(WVE) | COM | Y95308105 | $2.2K | 44,841 | 0.0% |
| Constellation Pharmaceuticals Inc(CNST) | COM | 210373106 | $1.9K | 280,000 | 0.0% |
| Forty Seven Inc(FTSVEUR) | COM | 34983P104 | $1.5K | 99,000 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $1.4K | 379,753 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $1.3K | 462,068 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $1.2K | 41,037 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $590 | 69,569 | 0.0% |